NEOG.NASDAQNeogen CORP

Form 4: NEOGEN Director Boosts Stake with Stock and Options

Sentiment:

Insider Transaction Report


NEOGEN Director Thierry Bernard acquired 19,769 shares of common stock and 50,814 derivative securities, signaling increased insider ownership.

Summary

  • Thierry Bernard, a Director at NEOGEN CORP (NEOG), acquired additional beneficial ownership in the company.
  • The transaction involved the acquisition of 19,769 shares of Common Stock.
  • The acquisition price for the Common Stock was $6.07 per share.
  • Additionally, 50,814 derivative securities, specifically a 'Right to Buy' Common Stock, were acquired.
  • The exercise price for these derivative securities is $6.07 per share.
  • Both the Common Stock and derivative securities were acquired on October 23, 2025.
  • Options and Restricted Stock Units (RSUs) associated with these grants will vest in equal annual installments over the first three anniversary dates of the grants.

Sentiment

Score: 7

Explanation: The acquisition of shares and derivative securities by a director is generally viewed as a positive signal, indicating management's confidence in the company's future performance and valuation.

Positives

  • Increased insider ownership by a Director, which can signal confidence in the company's future prospects.
  • The acquisition of both direct common stock and derivative securities demonstrates a multi-faceted commitment from the insider.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

  • Shareholders may interpret the director's increased stake as a positive indicator of future company performance and alignment of interests between management and shareholders.

Next Steps

  • Vesting of options and RSUs in equal annual installments on the first three anniversary dates of the grants (October 23, 2026, 2027, and 2028).

Key Dates

DateDescription
10/23/2025Transaction date for the acquisition of Common Stock and Derivative Securities.
10/23/2026First anniversary date for the vesting of options and RSUs.
10/23/2027Second anniversary date for the vesting of options and RSUs.
10/23/2028Third anniversary date for the vesting of options and RSUs.
10/23/2035Expiration date for the acquired derivative securities (Right to Buy).
10/27/2025Date the Form 4 was signed by the reporting person's attorney-in-fact.

Recommendation

hold

While insider buying is generally a positive signal, indicating management's confidence, a single Form 4 filing typically does not provide enough comprehensive information to warrant a 'buy' or 'sell' recommendation on its own. It should be considered as one data point among many in a broader investment analysis. Therefore, a 'hold' recommendation is appropriate, acknowledging the positive signal while advising for further due diligence.

Keywords

NEOGEN, NEOG, Insider Trading, Form 4, Director Acquisition, Stock Purchase, Derivative Securities, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.